摘要
目的观察持续性血液滤过治疗顽固性心衰对临床指标的影响。方法抽取2017年2月—2018年4月本院收治的82例顽固性心衰患者作为研究对象。根据治疗方案的不同,将82例患者分为对照组、治疗组,每组均41例。对照组应用常规方案治疗,基于此,治疗组用持续性血液滤过治疗,对比两种治疗方案对心功能、血清炎症因子、治疗总有效率的影响。结果与对照组相比,治疗组患者心功能较优,差异具有统计学意义(P <0.05);与对照组相比,治疗组患者血清炎症因子较低,差异具有统计学意义(P <0.05);与对照组相比,治疗组患者的治疗总有效率较高,差异具有统计学意义(P <0.05)。结论在顽固性心衰临床治疗中,应用持续性血液滤过治疗,不仅可以改善心功能、血清炎症因子,还可以提高治疗总有效率,临床应用价值较高。
Objective To observe the effect of continuous hemofiltration on clinical indicators of refractory heart failure.Methods 82 patients with refractory heart failure admitted to our hospital from February 2017 to April 2018 were selected as the study subjects.According to the different treatment schemes,82 patients were divided into control group and treatment group,41 cases in each group.The control group was treated with routine regimen.Based on this,the treatment group was treated with continuous hemofiltration.To compare the effects of two treatment schemes on cardiac function,serum inflammatory factors and total effective rate of treatment.Results Compared with the control group,the cardiac function of the patients in the treatment group was better,with statistical significance(P<0.05).Compared with the control group,the serum inflammatory factors in the treatment group were lower,the difference was statistically significant(P<0.05).Compared with the control group,the total effective rate of the treatment group was higher,the difference was statistically significant(P<0.05).Conclusion In the clinical treatment of refractory heart failure,the application of continuous hemofiltration treatment can not only improve heart function,serum inflammatory factors,but also improve the total effective rate of treatment.
作者
李松
江倩
LI Song;JIANG Qian(Department of Cardiology,Jingzhou City Traditional Chinese Medicine Hospital,Jingzhou Hubei 434000,China;Department of Nephrology,Jingzhou City Traditional Chinese Medicine Hospital,Jingzhou Hubei 434000,China)
出处
《中国继续医学教育》
2019年第3期71-74,共4页
China Continuing Medical Education
关键词
持续性血液滤过
顽固性心衰
心功能
血清炎症因子
治疗效果
影响
persistent hemofiltration
refractory heart failure
cardiac function
serum inflammatory factor
therapeutic effect
influence